The JS001sc-002-III-NSCLC Study is a multi-center, open-label, randomized Phase 3 clinical study led by the principal investigator Professor Lin WU from Hunan Cancer Hospital. JS001sc-002-III-NSCLC is ...
For the quarter ending December 31, 2025, management expects gross revenue of more than US$30.0 million from sales of Ryoncil ® (remestemcel-L-rknd). This represents more than 37% increase on the ...
The world-renowned, peer-reviewed, open-access Nature journal, Signal Transduction and Targeted Therapy, publishes original research on cutting-edge experimental and clinical advances on ...
Jeanette Yoffe Publishes "The Traumatized and At-Risk Youth Toolbox," Her Newest Guidebook With Over 160 Attachment-Informed Interventions for Working with Kids and Families in Foster Care and Beyond ...
The webcast of the fireside chat discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days ...
Radiant Health Centers invites the public to a free World AIDS Day Policy Forum and the kickoff of its 40th Anniversary Celebration on December 1 at the Norma Herzog Community Center in Costa Mesa.
8th Annual Evercore Healthcare Conference Date: Wednesday, December 3, 2025 at 8:45 am E.T. Location: Coral Gables, FL Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, ...
HYRNUO is a reversible kinase inhibitor of human epidermal growth factor receptor 2 (HER2). In vitro, HYRNUO inhibited the phosphorylation of HER2, downstream signaling in cancer cells with HER2 ...
NOVATO, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for ...
The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at https://ir.aurabiosciences.com/events-and ...
A live audio webcast of the presentation will be accessible under the Events & Presentations section of AVITA Medical's website at https://ir.avitamedical.com/events-and-presentations. A replay of the ...
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the BTIG 5 th Annual Ophthalmology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback